Home › Funds › MONTANOVA CAPITAL, LLC › BNTC

MONTANOVA CAPITAL, LLC position in BNTC

BENITEC BIOPHARMA INC · Health Care

MONTANOVA CAPITAL, LLC reported holding 11,548,351 shares of BNTC (BENITEC BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$154.5M, representing 2.83% of its reported portfolio and ranking #7 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed BNTC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)11.55M sh
Reported value held$154.52M
Portfolio Weight2.83%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONTANOVA CAPITAL, LLC's BNTC position evolved

MONTANOVA CAPITAL, LLC first disclosed a stake in BNTC in Q3 2023 at 204,220 shares (US$617K). The position peaked in Q4 2025 at 11,548,351 shares, worth US$155.6M. Across 12 filings, MONTANOVA CAPITAL, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 11,548,351 shares valued at US$154.5M. Notable position changes include a 728% increase in Q2 2024 (shares rose 31% over the following quarter), a 422% increase in Q3 2024 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 204.22K $617.09K New
Q4 2023 204.22K $659.63K Hold
Q1 2024 204.22K $1.07M Hold
Q2 2024 1.69M $11.82M Add
Q3 2024 8.83M $81.14M Add
Q4 2024 8.96M $113.16M Add
Q1 2025 9.88M $128.49M Add
Q2 2025 9.88M $115.56M Hold
Q3 2025 9.88M $138.57M Hold
Q4 2025 11.55M $155.56M Add
Q1 2026 11.55M $122.99M Hold
Q2 2026 11.55M $154.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTC and 13F data

BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 56 other funds we track also report a position in BNTC — the largest reported positions include Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M), INFINITUM ASSET MANAGEMENT, LLC (US$12.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTC

All BNTC fund holders →

FAQ

How long has MONTANOVA CAPITAL, LLC held BNTC?

MONTANOVA CAPITAL, LLC has disclosed BNTC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is MONTANOVA CAPITAL, LLC's current position in BNTC?

As of Q2 2026, MONTANOVA CAPITAL, LLC holds 11.55M shares of BNTC (BENITEC BIOPHARMA INC), valued at $154.52M, representing 2.83% of its reported portfolio and ranking #7.

Has MONTANOVA CAPITAL, LLC been buying or selling BNTC?

In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC held unchanged its position in BNTC. The position peaked in Q4 2025 at 11.55M shares.

Which other funds hold BNTC?

Other major institutional holders of BNTC include Nantahala Capital Management, LLC, Simplify Asset Management Inc., INFINITUM ASSET MANAGEMENT, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.